Glotope Advanced Pharmaceutical Technology Ltd
Glotope is a one-stop rCRO/CDMO platform dedicated to tackling universal challenges in the radiopharmaceutical industry and professionally catalyzing projects with high-potential.
As a pioneering bridge for innovative radiopharmaceuticals entering the Chinese market, Glotope operates from dual headquarters in Chengdu and Beijing, China. We proudly operate 3 production sites located in Jiangsu, Guangdong, and Sichuan, which collectively house >100 hot cells with operational qualifications for >40 types of nuclides, including 177Lu, 225Ac, 212Pb, 68Ga, 18F, 64Cu, 203Pb, and 89Zr. Our expertise spans from PCC verification to IND and ultimately to NDA and commercialization, offering a comprehensive suite of services including early screening, process development, pharmacokinetics and safety evaluation, clinical transformation, registration application, IRC independent evaluation solutions and commercial production.
Overall Glotope provides tailored support for radiopharmaceuticals companies and big pharma interested in entering the radiopharmaceutical industry in China, where robust validations and data generated can in turn powerfully leverage the global development progress